[Formula: see text], a Rare Protopanaxatriol-Type Ginsenoside Fraction from Black Ginseng, Suppresses Inflammatory Gene iNOS via the Iinhibition of p-STAT-1 and NF-[Formula: see text]B

Am J Chin Med. 2020;48(5):1091-1102. doi: 10.1142/S0192415X20500536.

Abstract

Black ginseng (BG), which is ginseng that has been steamed and dried nine times, and its main protopanaxatriol-type ginsenosides Rg4, Rg6, Rh4, and Rg2 have been reported to exhibit various forms of biological activity, including antiseptic, antidiabetic, wound-healing, immune-stimulatory, and anti-oxidant activity. The aim of the this study was to examine the effects of [Formula: see text] (a rare protopanaxatriol-type ginsenoside fraction; Rg2, Rg4, Rg6, Rh1, and Rh4) on heme oxygenase-1 (HO-1) induction and on the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX-)2 in lipopolysaccharide (LPS)-activated human pulmonary artery endothelial cells (HPAECs). [Formula: see text] was tested to determine its effect on iNOS protein expression and inflammatory markers (interleukin [IL]-1[Formula: see text] and tumor necrosis factor [TNF]-[Formula: see text] in the lung tissue of LPS-treated mice. The results showed that [Formula: see text] induced the expression of HO-1, reduced LPS-activated NF-[Formula: see text]B-luciferase activity, and inhibited iNOS/NO and COX-2/PGE2, which contributed to the inhibition of STAT-1 phosphorylation. In particular, [Formula: see text] induced the translocation of Nrf2 from the cytosol to the nucleus by increasing Nrf2-ARE activity and decreased IL-1[Formula: see text] production in LPS-activated HPAECs. This reduction in iNOS/NO expression due to [Formula: see text] was reversed by siHO-1 RNA transfection. In LPS-treated mice, [Formula: see text] significantly reduced lung tissue iNOS protein levels and TNF-[Formula: see text] levels in the bronchoalveolar lavage fluid. In conclusion, these findings indicate that [Formula: see text] has a critical anti-inflammatory effect due to its ability to regulate iNOS via the inhibition of p-STAT-1 and NF-[Formula: see text]B, and thus it may be suitable for the treatment of inflammatory disease.

Keywords: Endothelium; [Formula: see text]; iNOS; p-STAT-1.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents
  • Cyclooxygenase 2 / genetics
  • Cyclooxygenase 2 / metabolism
  • Gene Expression / drug effects*
  • Ginsenosides / isolation & purification
  • Ginsenosides / pharmacology*
  • Heme Oxygenase-1 / metabolism
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Inflammation / drug therapy
  • Inflammation / genetics*
  • Inflammation Mediators / metabolism
  • Interleukin-1beta / metabolism
  • Luciferases / metabolism
  • Male
  • Mice, Inbred C57BL
  • NF-kappa B / metabolism*
  • Nitric Oxide Synthase Type II / genetics*
  • Nitric Oxide Synthase Type II / metabolism*
  • Panax / chemistry*
  • Phosphorylation / drug effects
  • Phytotherapy
  • STAT1 Transcription Factor / metabolism*

Substances

  • Anti-Inflammatory Agents
  • Ginsenosides
  • Inflammation Mediators
  • Interleukin-1beta
  • NF-kappa B
  • STAT1 Transcription Factor
  • STAT1 protein, human
  • Luciferases
  • Nitric Oxide Synthase Type II
  • Heme Oxygenase-1
  • Cyclooxygenase 2